![Nicholas Grund](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicholas Grund
Corporate Officer/Principal bei
AKEBIA THERAPEUTICS, INC.
Vermögen: 337 330 $ am 31.05.2026
Profil
Nicholas P.
Grund is Chief Commercial Officer & Senior Vice President at Akebia Therapeutics, Inc. since 2024.
Formerly, Mr. Grund was Head-Specialty Care at Genzyme Corp.
from 2007 to 2015, Chief Commercial Officer & Executive VP at AMAG Pharmaceuticals, Inc. from 2016 to 2019, President-Eurofins at Transplant Genomics, Inc. from 2021 to 2022, and Principal at Bayer Diagnostics Corp.
from 1995 to 2002.
Mr. Grund earned an MBA from Northeastern University and completed undergraduate studies at the University of Massachusetts.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 330.716 ( 0,12 % ) | 337 330 $ | 31.05.2026 |
Aktive Positionen von Nicholas Grund
| Unternehmen | Position | Beginn |
|---|---|---|
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | 09.01.2024 |
Ehemalige bekannte Positionen von Nicholas Grund
| Unternehmen | Position | Ende |
|---|---|---|
Transplant Genomics, Inc.
 Transplant Genomics, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which focuses on kidney transplant recipients | Corporate Officer/Principal | 01.11.2022 |
| AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 29.03.2019 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01.12.2015 |
Bayer Diagnostics Corp.
 Bayer Diagnostics Corp. Medical SpecialtiesHealth Technology Provides diagnostic and research services | Corporate Officer/Principal | 01.01.2002 |
Ausbildung von Nicholas Grund
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Bayer Diagnostics Corp.
Bayer Diagnostics Corp. Medical SpecialtiesHealth Technology Provides diagnostic and research services | Health Technology |
Transplant Genomics, Inc.
Transplant Genomics, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which focuses on kidney transplant recipients | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
